Equities

Reska Biotech Inc

GWIN:PKL

Reska Biotech Inc

Actions
  • Price (USD)0.1021
  • Today's Change0.00 / 0.00%
  • Shares traded2.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 16 2024 16:46 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

GLORYWIN ENTERTAINMENT GROUP INC., formerly TOP HONESTY GROUP INC., focuses on providing information technology (IT) solutions, junket services and mobile application development for the gaming industry, as well as operating land-based casinos. It introduces very important person (VIP) players to casinos throughout the Asian region, receiving an agreed percentage of total bets placed. It provides junket services to approximately 25 online sub-junkets, where gamers can play various casino games, such as Roulette, Baccarat and Blackjack, among others. It provides sub-junkets and IT infrastructure to land-based casinos in Cambodia. It offers a mobile application to provide gaming to customers where such activity is legal. It also provides technical support services to the casinos regarding their online casino platforms and has acquired the operating rights to a land-based casino in Cambodia.

  • Revenue in USD (TTM)0.00
  • Net income in USD-2.06m
  • Incorporated2010
  • Employees1.00
  • Location
    Reska Biotech IncRoom 8, 20/F, Aia TowerNo's 251A-301Avenida Commercial De MacauMACAU XXXXXMacauMAC
  • Phone+853 82942333
  • Websitehttp://www.tophonestygroup.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Table Trac Inc10.94m1.64m18.68m37.0011.351.7011.271.710.3550.3552.372.370.89841.325.56295,574.3013.5115.2115.1118.1669.7569.9415.0415.226.78--0.00---14.203.94-0.704225.652.04--
Kenilworth Systems Corporation8.00k-333.85k22.22m3.00------2,777.95-0.0038-0.00380.0001-0.00050.1353--1.60---564.79------62.50---4,173.13-----6.15---------1,143.64------
Reska Biotech Inc0.00-2.06m36.37m1.00---------0.0199-0.01990.00-0.00110.00-------822,180.00-115.48---157.28-------43.08---------100.00--29.07------
Greenlite Ventures Inc0.00-369.94k50.05m0.00---------0.1426-0.14260.00-0.08940.00-------729.45-259.73-------------------------189.34------
High Roller Technologies Inc28.87m-4.46m59.93m----67.16--2.08-0.5393-0.53933.490.108----------------53.21---15.44-----40.070.00--60.48--7.86------
Galaxy Gaming Inc30.91m-2.57m68.43m46.00----431.812.21-0.1009-0.10091.22-0.77530.7603--6.64671,896.10-6.31-0.533-7.28-0.621594.9198.20-8.30-0.8655--0.7591.55--18.548.412.27--105.76--
Canterbury Park Holding Corp62.11m4.72m102.30m227.0021.601.2012.421.650.94370.943712.4216.970.576545.6230.46273,620.304.388.574.979.9078.8078.577.6012.002.2217.150.001913.03-8.060.764440.6013.777.540.00
Century Casinos, Inc.581.91m-74.10m132.86m3.24k--2.34--0.2283-2.42-2.4219.061.850.437373.4336.59179,436.00-4.95-1.24-5.74-1.3944.6248.33-11.32-2.501.740.55620.8687--27.8026.64-453.54--0.9834--
Full House Resorts Inc279.13m-40.86m170.17m1.55k--3.27--0.6097-1.18-1.188.041.460.418567.0839.54180,201.40-6.13-1.75-6.69-1.9551.4353.26-14.64-3.850.8284-0.07570.9008--47.648.02-68.22--54.19--
Data as of Sep 16 2024. Currency figures normalised to Reska Biotech Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.